These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 22691154)
1. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis. Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents. Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
4. Maximizing bactericidal activity with combinations of bioreduced drugs. Goldman RC Future Med Chem; 2010 Aug; 2(8):1253-71. PubMed ID: 21426017 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages. Zhang H; Lu Q; Zhang J; Qu W; Xie S; Huang L; Yuan Z; Pan Y Eur J Med Chem; 2021 Nov; 223():113657. PubMed ID: 34217060 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide. Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817 [TBL] [Abstract][Full Text] [Related]
7. Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent. Gallardo-Macias R; Kumar P; Jaskowski M; Richmann T; Shrestha R; Russo R; Singleton E; Zimmerman MD; Ho HP; Dartois V; Connell N; Alland D; Freundlich JS Bioorg Med Chem Lett; 2019 Feb; 29(4):601-606. PubMed ID: 30600207 [TBL] [Abstract][Full Text] [Related]
8. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706 [TBL] [Abstract][Full Text] [Related]
9. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents. Tao X; Gao C; Huang ZG; Luo W; Liu KL; Peng CT; Ding CZ; Li J; Chen SH; Yu LT Bioorg Med Chem Lett; 2019 Sep; 29(17):2511-2515. PubMed ID: 31353295 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents. Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380 [TBL] [Abstract][Full Text] [Related]
12. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis. Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815 [TBL] [Abstract][Full Text] [Related]
13. Allylic thiocyanates as a new class of antitubercular agents. Silveira GP; Ferreira M; Fernandes L; Moraski GC; Cho S; Hwang C; Franzblau SG; Sá MM Bioorg Med Chem Lett; 2012 Oct; 22(20):6486-9. PubMed ID: 22967767 [TBL] [Abstract][Full Text] [Related]
14. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity. Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749 [TBL] [Abstract][Full Text] [Related]
16. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents. Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474 [TBL] [Abstract][Full Text] [Related]
19. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis. Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides. Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]